DekaBank Deutsche Girozentrale’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.14M Hold
30,000
0.01% 560
2025
Q1
$4.57M Hold
30,000
0.01% 581
2024
Q4
$4.11M Hold
30,000
0.01% 614
2024
Q3
$4.32M Hold
30,000
0.01% 616
2024
Q2
$4.05M Hold
30,000
0.01% 624
2024
Q1
$4.44M Hold
30,000
0.01% 603
2023
Q4
$3.81M Hold
30,000
0.01% 637
2023
Q3
$2.84M Hold
30,000
0.01% 665
2023
Q2
$2.64M Buy
30,000
+10,000
+50% +$878K 0.01% 690
2023
Q1
$2.15M Hold
20,000
0.01% 711
2022
Q4
$2.41M Hold
20,000
0.01% 681
2022
Q3
$2.04M Buy
20,000
+4,940
+33% +$503K 0.01% 701
2022
Q2
$1.39M Sell
15,060
-9,000
-37% -$832K ﹤0.01% 801
2022
Q1
$2.79M Buy
24,060
+2,200
+10% +$255K 0.01% 686
2021
Q4
$2.9M Buy
21,860
+590
+3% +$78.3K 0.01% 693
2021
Q3
$3.33M Hold
21,270
0.01% 627
2021
Q2
$2.83M Hold
21,270
0.01% 654
2021
Q1
$2.73M Buy
21,270
+10,000
+89% +$1.28M 0.01% 626
2020
Q4
$1.89M Sell
11,270
-560
-5% -$93.7K 0.01% 682
2020
Q3
$1.8M Buy
+11,830
New +$1.8M 0.01% 611
2019
Q3
Sell
-14,000
Closed -$1.52M 999
2019
Q2
$1.52M Sell
14,000
-13,100
-48% -$1.42M 0.01% 696
2019
Q1
$1.92M Buy
27,100
+4,950
+22% +$350K 0.01% 620
2018
Q4
$1.35M Sell
22,150
-4,950
-18% -$301K 0.01% 616
2018
Q3
$1.92M Buy
27,100
+22,300
+465% +$1.58M 0.01% 633
2018
Q2
$315K Sell
4,800
-16,000
-77% -$1.05M ﹤0.01% 990
2018
Q1
$1.32M Buy
+20,800
New +$1.32M 0.01% 655